DANBURY, Conn., Sept. 17 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) announced today the appointment of Arthur Urciuoli to the company's board of directors. Mr. Urciuoli is chairman of ArcherGroup, a private investment and consulting services firm, and was recently elected to the board of the newly-formed Kroll Bond Rating Agency. He is a retired chairman of Merrill Lynch International and former director of Kroll, Inc. He spent 30 years at Merrill Lynch & Company where he held a variety of senior leadership positions, including chairman and chief executive of Merrill Lynch Business Financial Services and director of Merrill Lynch Private Banking, and was a syndicated columnist and frequent guest speaker on investing and business management.
Biodel's president and chief executive officer, Dr. Errol De Souza, stated: "Archie Urciuoli has an outstanding record of achievement in international finance and corporate governance. We believe his experience in financing public companies and developing successful business strategies will be extremely valuable as we work to build our product pipeline and company. We welcome his counsel and contributions to our future success."
Mr. Urciuoli stated: "I am honored to join the Biodel board at this important time in the company's history. With one product candidate under review for U.S. marketing approval and other drugs advancing into clinical development, Biodel faces exciting opportunities to improve the lives of people with diabetes and become a successful pharmaceutical company. I look forward to working with the rest of the board and a very talented management team to help realize the company's full potential."
Mr. Urciuoli was a captain in the U.S. Marine Corps and is a graduate of St. Lawrence University, Georgetown University Law School and the